Munafa Stock Market Course + Intraday & FNO calls 
CAL NEWS why is Caleres, Inc. price falling or rising
CAL NEWS reasons for why stock price of Caleres, Inc. is falling or rising
CAL Caleres Inc is falling or rising technical reasons
Technical analysis forecast for Caleres Inc Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Caleres Inc CAL at this time. Stock is falling and might fall more.
It appears as if Caleres Inc CAL gave a large move recently.
Stock of Caleres Inc (CAL) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.
My analysis of Caleres Inc is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Caleres Inc stays below 12.1, but if it comes above 12.1, then a intra day buy could be more profitable.
If you take a sell trade below 12.1, then use 12.1 as stoploss and 11.4 as target. However if you take a buy trade in Caleres Inc, then use 12.1 as stoploss and 12.73 as target.
CAL Caleres Inc is falling or rising NEWS fundamental reasons
ECDS to set up medical equipment manufacturing unit with ?780 cr investment ECDS, a company specialised in sustainable development technologies, on Wednesday announced it will set up a medical equipment manufacturing unit in Ujjain with an initial investment of Rs 780 crore under a joint venture with three South Korean companies. - NEWS as on 2026-02-12 business-standard.com
India's medical devices industry to reach USD 50.1 billion by 2030: Report According to the report, growth is being propelled by government initiatives such as National Medical Devices Policy (NMDP), Production-Linked Incentive (PLI) Scheme, Scheme for Promotion of Medical Devices Parks, and MedTech Mitra. The study assumes great - NEWS as on 2026-02-11 indiatimes.com
Cubical Financial Services reports standalone nil net profit/loss in the December 2025 quarter Sales decline 8.11% to Rs 0.34 crore - NEWS as on 2026-02-10 business-standard.com
Vertiv Holdings: Powering the AI Boom with Critical Infrastructure Solutions This stock has risen nearly 25% this year alone amid broadening recognition of its role in the AI ecosystem. - NEWS as on 2026-02-10 nasdaq.com
3 Chemical Specialty Stocks to Watch Amid Demand Headwinds Weak end-market demand dampens the prospects of the Zacks Chemicals Specialty industry. SQM, ESI and FSI lean on cost cuts and expansion moves to navigate the ongoing challenges. - NEWS as on 2026-02-09 nasdaq.com
‘AI’ the most underappreciated vertical in Reliance Industries: Morgan Stanley The firm keeps Reliance as a top pick with an Overweight rating and an unchanged price target of Rs 1,803, implying 24% upside from the February 6 close of Rs 1,451. - NEWS as on 2026-02-09 indiatimes.com
Profit Therapy: 3 Medical Stocks Ready to Deliver Q4 Beat THC, UHS and OPCH look poised to beat Q4 estimates as volumes, admissions and revenue trends improve. - NEWS as on 2026-02-06 nasdaq.com
Technical issues at depositories delays settlement of stock trades Brokerages face continued trade settlement issues even as NSDL says systems are back to normal, leaving some investors unable to sell stocks - NEWS as on 2026-02-06 business-standard.com
ETMarkets Smart Talk: India’s US & EU trade deals reduce geopolitical risk for investors, says Pradeep Gupta India's recent trade agreements with the US and EU are reducing geopolitical risk, strengthening its investment case. The Budget prioritizes structural growth through public capex and industrial policy, not short-term consumption, benefiting infrastructure - NEWS as on 2026-02-05 indiatimes.com
3 Chemical Stocks Poised to Outshine Q4 Earnings Estimates ALB, SQM and MEOH face weak end-market demand, but self-help measures, including cost cuts and productivity gains, position them to beat Q4 earnings estimates. - NEWS as on 2026-02-05 nasdaq.com
IT stocks crash: JPMorgan analysts decode the logical and illogical reaction JPMorgan says the recent global IT selloff amid AI disruption fears has veered from rational concern to outright panic. Analyst Mark Murphy noted that markets are “overwhelmingly” focused on AI headlines, ignoring enterprise software resilience. The IGV te - NEWS as on 2026-02-04 indiatimes.com
Chemical stocks surge up to 19% on US-India trade deal. Why brokerages see Aarti, UPL, 2 more stocks as top beneficiaries Chemical stocks surged as the US-India trade deal lowered export tariffs to 18%, boosting margins, volumes and competitiveness. Brokerages cite operating leverage, China-plus-one benefits and rupee strength as key drivers supporting a sharp sector-wide ral - NEWS as on 2026-02-03 indiatimes.com
US tariff cut to 18% to boost India’s medical device exports India's medical device exports to the US will surge following a tariff cut. This move makes Indian products more competitive against China. Lower import duties will also benefit India's healthcare system by reducing costs for high-value equipment. Industry - NEWS as on 2026-02-03 indiatimes.com
Budget predictability, fiscal discipline positive, but liquidity remains key challenge: Neelkanth Mishra India's Union Budget prioritizes continuity amid global uncertainty, with fiscal discipline largely achieved. While borrowing targets raise concerns, the focus shifts to proactive liquidity management to ensure fiscal discipline translates into lower borro - NEWS as on 2026-02-02 indiatimes.com
4 Medical Product Stocks to Watch From a Challenging Industry The Zacks Medical products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals. - NEWS as on 2026-02-02 nasdaq.com
More announcements and NEWS
CAL Caleres, Inc. current price & indicator signals
Recent prices of CAL Caleres, Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 11 Wed Feb 2026 | 11.97 | 11.69 to 12.54 | -1.48% | 0.88 times |
| 10 Tue Feb 2026 | 12.15 | 12.06 to 12.55 | -2.57% | 0.85 times |
| 09 Mon Feb 2026 | 12.47 | 12.40 to 12.90 | -3.93% | 0.85 times |
| 06 Fri Feb 2026 | 12.98 | 12.62 to 13.05 | 3.18% | 0.86 times |
| 05 Thu Feb 2026 | 12.58 | 12.42 to 13.70 | -6.33% | 1.36 times |
| 04 Wed Feb 2026 | 13.43 | 13.00 to 13.64 | 4.6% | 1.18 times |
| 03 Tue Feb 2026 | 12.84 | 12.65 to 13.36 | 1.18% | 1.03 times |
| 02 Mon Feb 2026 | 12.69 | 12.24 to 12.72 | 3.85% | 0.78 times |
| 30 Fri Jan 2026 | 12.22 | 11.94 to 12.57 | -0.89% | 1.15 times |
| 29 Thu Jan 2026 | 12.33 | 12.26 to 12.63 | 0.24% | 0.75 times |
| 28 Wed Jan 2026 | 12.30 | 12.03 to 12.80 | -3% | 1.2 times |
| 27 Tue Jan 2026 | 12.68 | 12.29 to 12.77 | 0% | 0.95 times |
Videos related to: CAL NEWS why is Caleres, Inc. price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
